From November 5th to 6th, 2025, the Alliance for Regenerative Medicine (ARM) hosted a 2-day workshop to explore the next phase of the CGT sector. Bringing together developers, clinicians, patient advocates, and other key stakeholders from across the CGT industry, this workshop represented ARM’s continued commitment to helping the global CGT sector achieve modernization in healthcare systems, overcome obstacles to innovation, and increase patient access to life-changing treatments. The workshop extended momentum from a UK-based workshop on CGT manufacturing and industrialization in the spring of 2025.

This whitepaper explores the takeaways and recommendations from the panelists and discussions at the workshop. The full version is available to ARM members for free on ARM's member platform. Non-members can purchase access to the whitepaper. If you're an ARM member and need support accessing your account, please contact [email protected] for assistance.

View a short preview of the whitepaper document in the link below.